Intervacc AB (publ)
IVACC
Rank in Stocks
#25202
Intervacc AB (publ) is a Swedish biotechnology company primarily engaged in the... Intervacc AB (publ) is a Swedish biotechnology company primarily engaged in the research and development of innovative vaccines designed to combat bacterial infections in animal health. The firm's vaccine pipeline targets various animals, including horses, piglets, and dairy cows, with its key product, Strangvac, specifically developed to prevent equine strangles. Beyond its current offerings, Intervacc is also advancing vaccines against Streptococcus suis and Staphylococcus aureus infections. In addition to vaccine development, the company distributes veterinary medicines and provides essential diagnostic services in veterinary bacteriology to clinics and stud farms. Headquartered in Hägersten, Sweden, Intervacc serves customers across the Nordic countries and the Baltic states.
Share Price
$0.08090673
Last synced: 2026-11-09
Market Cap
$27.57M
Change (1 day)
2.87%
Change (1 year)
-15.70%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Intervacc AB (publ) (IVACC)
Category
Healthcare
Operating Margin for Intervacc AB (publ) (IVACC)
Operating Margin as of November 2026 TTM: -528.92%
According to Intervacc AB (publ)'s latest financial reports, its current operating margin (TTM) is -528.92%. At the end of 2025 the company had an operating margin of -422.45%.
Operating Margin history for Intervacc AB (publ) from 2013 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -528.92% | 25.20% |
| 2025 | -422.45% | -35.56% |
| 2024 | -655.61% | -43.85% |
| 2023 | -1,167.55% | 75.53% |
| 2022 | -665.15% | 18.60% |
| 2021 | -560.83% | 4.41% |
| 2020 | -537.15% | 134.14% |
| 2019 | -229.41% | 164.15% |
| 2018 | -86.85% | 204.74% |
| 2017 | -28.50% | 114.12% |
| 2016 | -13.31% | -502.11% |
| 2015 | 3.31% | -74.44% |
| 2014 | 12.95% | -104.20% |
| 2013 | -308.39% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.07% |
US
|
|
| -149.01% | -99.72% |
US
|
|
| 25.57% | -100.05% |
AU
|
|
| 31.23% | -100.06% |
BE
|
|
| 29.35% | -100.06% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Intervacc AB (publ)'s operating margin
What is Intervacc AB (publ)'s operating margin?
Intervacc AB (publ)'s operating margin is -528.92%, as of Nov 2026.
What was Intervacc AB (publ)'s operating margin in 2025?
In 2025, Intervacc AB (publ)'s operating margin was -422.45%, compared with -655.61% in 2024.
How has Intervacc AB (publ)'s operating margin changed since 2020?
From 2020 to 2025, Intervacc AB (publ)'s operating margin was highest in 2025 (-422.45%) and lowest in 2023 (-1,167.55%).
How does Intervacc AB (publ)'s operating margin compare with similar companies?
Intervacc AB (publ)'s operating margin (-528.92%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.